{"schema_version":"secwatch.filing_event.v1","accession":"0000313143-24-000009","form_type":"8-K","ticker":"HAE","cik":"0000313143","company_name":"HAEMONETICS CORP","filed_at":"2024-03-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.537689+00:00","generated_at":"2026-06-05T04:17:31.964568+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Haemonetics to acquire Attune Medical for $160M upfront; device complements EP portfolio","bullets":["Upfront cash $160M plus contingent consideration based on sales growth and milestones.","Attune Medical's ensoETM device reduces esophageal injury during cardiac ablation; revenue $22M in 2023, doubled YoY.","Transaction expected to close in Q1 fiscal 2025 (April-June 2024) subject to customary conditions.","Haemonetics expects immediate accretion to revenue and earnings growth; financed via cash and revolver."],"urls":{"canonical":"https://secwatch.observer/filing/0000313143-24-000009","json":"https://secwatch.observer/filing/0000313143-24-000009.json","markdown":"https://secwatch.observer/filing/0000313143-24-000009.md","text":"https://secwatch.observer/filing/0000313143-24-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/313143/000031314324000009/0000313143-24-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/313143/000031314324000009/hae-20240305.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T04:17:31.964568+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}